Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 12, 2010, Pages 1844-1849

  Hanaoka, Noboru ^a   Uedo, Noriya ^a,b   Shiotani, Akiko ^a   Inoue, Takuya ^a   Takeuchi, Yoji ^a   Higashino, Koji ^a   Ishihara, Ryu ^a   Iishi, Hiroyasu ^a   Haruma, Ken ^a   Tatsuta, Masaharu ^a,b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Autofluorescence imaging; Early gastric cancer; Endoscopic submucosal dissection; Helicobacter pylori; Metachronous gastric cancer

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PEPSINOGEN I; PEPSINOGEN II; RABEPRAZOLE;

AGED; ARTICLE; ATROPHIC GASTRITIS; AUTOFLUORESCENCE IMAGING; COHORT ANALYSIS; DIAGNOSTIC IMAGING; DISEASE SEVERITY; EARLY CANCER; ENDOSCOPIC SUBMUCOSAL DISSECTION; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; METACHRONOUS GASTRIC CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STOMACH CANCER; VIDEOENDOSCOPY;

EID: 78649539985     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06442.x     Document Type: Article

References (28)

1. Gotoda T, Yanagisawa A, Sasako M et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric. Cancer. 2000; 3: 219-25.
2. Takeuchi Y, Uedo N, Iishi H et al. Endoscopic submucosal dissection with insulated-tip knife for large mucosal early gastric cancer: a feasibility study (with videos). Gastrointest. Endosc. 2007; 66: 186-93.
3. Isomoto H, Shikuwa S, Yamaguchi N et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 2009; 58: 331-6.
4. Ohkuwa M, Hosokawa K, Boku N et al. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 2001; 33: 221-6.
5. Kosaka T, Miwa K, Yonemura Y et al. A clinicopathologic study on multiple gastric cancers with special reference to distal gastrectomy. Cancer 1990; 65: 2602-5.
6. Nasu J, Doi T, Endo H, Nishina T et al. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy 2005; 37: 990-3.
7. Isozaki H, Okajima K, Hu X et al. Multiple early gastric carcinomas. Clinicopathologic features and histogenesis. Cancer 1996; 78: 2078-86.
8. Nakajima T, Oda I, Gotoda T et al. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? Gastric Cancer 2006; 9: 93-8.
9. Uedo N, Iishi H, Tatsuta M et al. Long term outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer 2006; 9: 88-92.
10. Fukase K, Kato M, Kikuchi S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-7.
11. Shiotani A, Uedo N, Iishi H et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008; 78: 113-9.
12. Inoue T, Uedo N, Ishihara R et al. Autofluorescence imaging videoendoscopy in the diagnosis of chronic atrophic fundal gastritis. J. Gastroenterol. 2010; 45: 45-51.
13. Kimura K, Takemoto T. An endoscopic recognition of the atrophy border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
14. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996; 20: 1161-81.
15. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-1.
16. Tatsuta M, Iishi H, Nakaizumi A et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int. J. Cancer 1993; 53: 70-4.
17. Tatsuta M, Saegusa T, Okuda S. Extension of fundal gastritis studied by endoscopic Congo-red test. Endoscopy 1974; 6: 20-6.
18. Uedo N, Iishi H, Tatsuta M et al. A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest. Endosc. 2005; 62: 521-8.
19. Ohata H, Kitauchi S, Yoshimura N et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int. J. Cancer 2004; 109: 138-43.
20. Mukoubayashi C, Yanaoka K, Ohata H et al. Serum pepsinogen and gastric cancer screening. Intern. Med. 2007; 46: 261-6.
21. De Vries AC, Haringsma J, De Vries RA et al. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest. Endosc. 2009; 70: 18-25.
22. Watabe H, Mitsushima T, Yamaji Y et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764-8.
23. Iijima K, Koike T, Abe Y et al. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J. Gastroenterol. 2009; 44: 819-25.
24. Wong BC, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
25. Yanaoka K, Oka M, Ohata H et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int. J. Cancer 2009; 125: 2697-703.
26. De Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am. J. Gastroenterol. 2009; 104: 1342-5.
27. Shimizu S, Tada M, Kawai K. Early gastric cancer: its surveillance and natural course. Endoscopy 1995; 27: 27-31.
28. Everett SM, Axon AT. Early gastric cancer: disease or pseudo-disease? Lancet 1998; 351: 1350-2.